Results 141 to 150 of about 2,755,321 (217)

Trends and determinants of isoniazid preventive therapy initiation in antiretroviral therapy-treated HIV-positive adults in Tanzania Mainland 2015-2020: a retrospective observational study using medical records. [PDF]

BMJ Open
Meela EB, Waria G, Shirima LJ, Mlay HL, Ngowi M, Maghembe AA, Meela J, Pallangyo DS, Balati J, Maokola W, Hugho E, Ngocho JS.   +11 more
europepmc   +1 more source

Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019. [PDF]

J Int AIDS Soc, 2022
Onyango DO, van der Sande MAB, Yuen CM, Mecha J, Matemo D, Oele E, Kinuthia J, John-Stewart G, LaCourse SM.   +8 more
europepmc   +1 more source

Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics. [PDF]

Clin Infect Dis
Montepiedra G, Aaron L, Theron G, McCarthy K, Bradford S, Chipato T, Vhembo T, Stranix-Chibanda L, Wabwire D, Masheto G, Jean-Philippe P, Sterling TR, Weinberg A, Gupta A.   +13 more
europepmc   +1 more source

Barriers and facilitators for isoniazid preventive therapy (IPT) administration in children under 5 years of age in the Dominican Republic. [PDF]

BMC Infect Dis, 2022
Benoit Vásquez GI, Morrobel AL, Benjumea-Bedoya D, Del Corral-Londoño H.   +3 more
europepmc   +1 more source

Outcomes of the Three-month Weekly Isoniazid With Rifapentine (3HP) Versus the Six-month Isoniazid Preventive Therapy (6H) Among People Newly Enrolled in HIV Care in Western Kenya. [PDF]

Open Forum Infect Dis
Onyango DO, Mecha JO, Njagi LN, Aoro S, Malika T, Kinuthia J, John-Stewart G, LaCourse SM.   +7 more
europepmc   +1 more source

Isoniazid Preventive Therapy Uptake and Its Effect on Tuberculosis Incidence Among People Living with HIV in Illubabor and Buno Bedelle Zones, South-West Ethiopia, 2022: A Retrospective Cohort Study. [PDF]

HIV AIDS (Auckl), 2023
Mulatu G, Gembe M, Chalchisa J, Teklu T, Yismaw W, Dereje D, Wondmagegn H.   +6 more
europepmc   +1 more source

Factors associated with completion of 6 months of isoniazid preventive therapy among under-five children exposed to tuberculosis patients in Blantyre, Malawi. [PDF]

J Public Health Afr
Mzama GT, Kaswaswa K, Chirwa T, Kagura J, Ibisomi L.   +4 more
europepmc   +1 more source

Isoniazid Preventive Therapy for Tuberculosis in People Living with HIV: A Cross Sectional Study in Butebo, Uganda. [PDF]

Infect Chemother, 2022
Oonyu L, Kang S, Konlan KD, Kang YA.
europepmc   +1 more source

Duration of isoniazid preventive therapy in HIV-infected patients [PDF]

The Lancet, 2011
openaire   +4 more sources

Characterizing isoniazid preventive therapy uptake among people living with human immunodeficiency virus in Tanzania, a resource-constrained setting with a high tuberculosis burden: A systematic review and meta-analysis. [PDF]

IJID Reg
Sindato EM, Kajogoo VD, Mchonde GJ, Mpondo BCT.   +3 more
europepmc   +1 more source